Fuyuan medicine is listed on the Shanghai Stock Exchange: the market value is 10.5 billion, and Hu Baifan is worth more than 4billion

RedI network Lei Jianping 7 month 1 Reported Wednesday

Beijing Fuyuan Pharmaceutical Co., Ltd （ abbreviation ：“ Fuyuan medicine ”, Ticker “601089“） Recently, it was listed on the Shanghai Stock Exchange .

Fuyuan medicine's issuing price this time is 14.62 element , issue 1.2 Million shares , The total amount raised is 17.54 One hundred million yuan .

Fuyuan pharmaceutical's share price today is 21.95 element , Market capitalization 105.36 One hundred million yuan .

Hu Baifan, chairman of XinHeCheng holding group, the actual controller of Fuyuan medicine, said in his listing speech , Making medicine is a dream that XinHeCheng had when it was founded , The determination to make medicine has a long history , And has not changed . Medicine is closely related to people's life , Medicine saves the dying and heals the wounded , Improve public health , Improve the quality of life , It is an industry that brings happiness to mankind , It is an industry worthy of our lifelong efforts .

“ Today, Fuyuan pharmaceutical motherboard is listed , Entered a new growth platform , Will face new opportunities and challenges , This is not only an important milestone for the company , It is also an important part of ushering in development and transformation . Fuyuan pharmaceutical, as the group's medical and health business segment , XinHeCheng actively performs its shareholder responsibilities , Strictly abide by the requirements of laws and regulations , Fully support the strategic development decisions of subsidiaries .”

Annual revenue 28 Billion

Fuyuan medicine is mainly engaged in the research and development of pharmaceutical preparations and medical devices 、 Production and marketing , Pharmaceutical preparations mainly cover cardiovascular system 、 Chronic kidney disease 、 Dermatosis 、 Digestive system 、 Diabetes mellitus 、 Mental nervous system 、 Gynecology and other product segments ; The medical device business is mainly clinical nursing products .

The prospectus shows , Fuyuan medicine 2019 year 、2020 year 、2021 The annual revenue is 24.25 One hundred million yuan 、25.35 One hundred million yuan 、28.38 One hundred million yuan ; The net profit is respectively 2.2 One hundred million yuan 、2.65 One hundred million yuan 、3.2 One hundred million yuan ; The net profit after deducting non profits is 2 One hundred million yuan 、2.5 One hundred million yuan 、3.05 One hundred million yuan .

At the end of each reporting period , The balance of accounts receivable of the company is 4.44 One hundred million yuan 、4.05 Million dollars 3.65 One hundred million yuan , The proportion in the current operating income is 18.30%、15.96% and 12.85%.

Fuyuan medicine 2022 Revenue in the first quarter of 2007 7.48 Billion , More than the same period last year 22.43%; Net profit 8599 Ten thousand yuan , That's up from a year ago 44.83%; Net profit attributable to shareholders of the parent company 8559.2 Ten thousand yuan , That's up from a year ago 42.86%; Deduct non net profit 7,965.66 Ten thousand yuan , That's up from a year ago 36.02%.

Hubaifan indirectly controls 76.29% equity

IPO front , XinHeCheng holdings holds 48.98% equity , For the controlling shareholder of the company ; Hubaifan indirectly controls the company through XinHeCheng holdings and qinjin investment 76.29% shares , For the actual controller of the company .

Hubaifan ,1962 year 10 born ,1982 year 8 Month to 1988 year 10 month , Serve as a teacher of dashiju vocational middle school in Xinchang County ;1988 year 11 Month to 1999 year 2 month , Serve as the director of Xinchang synthetic chemical plant ;1999 year 2 Month so far , Serve as the chairman of Zhejiang XinHeCheng Co., Ltd ;2008 year 11 Month so far , Serve as chairman and President of XinHeCheng Holding Group Co., Ltd ; Now he is also the chairman of XinHeCheng Co., Ltd 、 Chairman of Shaoxing Yuexiu Education Development Co., Ltd 、 Director of Beijing Hecheng real estate Holding Co., Ltd .

Huakang Taifeng holds 19.51%, Xuancheng Renhe holds 2.34%, Haining Zhongjian holds 1.86%.

IPO after , XinHeCheng holdings holds 36.73%, Qinjin investment holds 20.49%, Huakang Taifeng holds 14.63%, Xuancheng Renhe holds 1.75%, Haining Zhongjian holds 1.39%.

Hubaifan still holds about 39% Equity of , Based on this calculation , Hu Baifan is worth more than 40 Billion .

———————————————

Lei Di was founded by Lei Jianping, a senior media person , If reproduced, please indicate the source .